+30 210 6691 000 communications@lavipharm.com ΕΝ Follow Us: About Us R&D Products Partnering Investors News & Media Contact ΕΝ SEARCH INVESTORS Investors’ Relations Browse the Investors section, where according to the Code of Corporate Governance timely and accurate information are available to the investing public. Select the category that interests you and learn all the news for the listed Lavipharm SA, which trades on the Athens Stock Exchange since 1995 (LAVI). About Lavipharm Lavipharm is a dynamic, international healthcare company driven by creativity and innovation, always striving to provide access to improved healthcare solutions. Our Location Agias Marinas Street PO Box 59 GR-19002 Peania Attica, Greece +30 210 6691 000 Copyright© 2019 Lavipharm. All Rights Reserved | Terms of use | Website by LAZARIDIS Follow Us on Social: We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT ΕΝ GR (GR)

+30 210 6691 000 communications@lavipharm.com ΕΝ Follow Us: About Us R&D Products Partnering Investors News & Media Contact ΕΝ SEARCH Investors’ Relations Investors’ Relations Browse the Investors section, where according to the Code of Corporate Governance timely and accurate information are available to the investing public. Select the category that interests you and learn all the news for the listed Lavipharm SA, which trades on the Athens Stock Exchange since 1995 (LAVI). About Lavipharm Lavipharm is a dynamic, international healthcare company driven by creativity and innovation, always striving to provide access to improved healthcare solutions. Our Location Agias Marinas Street PO Box 59 GR-19002 Peania Attica, Greece +30 210 6691 000 Copyright© 2019 Lavipharm. All Rights Reserved | Terms of use | Website by LAZARIDIS Follow Us on Social: We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT ΕΝ GR (GR)

+30 210 6691 000 communications@lavipharm.com ΕΝ Follow Us: About Us R&D Products Partnering Investors News & Media Contact ΕΝ SEARCH Mundisal gel Mundisal gel Choline Salicylate and Cetalkonium Chloride Gel (87,1 mg/g+0,1 mg/g) in tubes of 15 g. About Lavipharm Lavipharm is a dynamic, international healthcare company driven by creativity and innovation, always striving to provide access to improved healthcare solutions. Our Location Agias Marinas Street PO Box 59 GR-19002 Peania Attica, Greece +30 210 6691 000 Copyright© 2019 Lavipharm. All Rights Reserved | Terms of use | Website by LAZARIDIS Follow Us on Social: We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT ΕΝ GR (GR)